Latest Prostate cancer Stories
A study of more than 87,000 individuals of European, African, Japanese and Latino ancestry has revealed 23 new genetic susceptibility locations indicating risk of prostate cancer, contributing to greater knowledge and hope for future prevention of the disease.
WHIPPANY, N.J., Sept.
A genetic discovery out of the University of Pittsburgh School of Medicine is leading to a highly accurate test for aggressive prostate cancer and identifies new avenues for treatment.
Data presented at American Society for Radiology (ASTRO) Annual Meeting in San Francisco SAN FRANCISCO, Sept.
Unusually broad range of tumors treated, other benefits seen in first seven months SAN FRANCISCO, Sept.
BETHESDA, Md., Sept. 15, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S.
A study led by University of Colorado Cancer Center published today in the journal Nature uses a novel approach to target the activation of a protein that drives some cancers. AURORA,
Philips reinforces its leadership in innovation and technology, showcases solutions that increase workflow, consistency and confidence in cancer treatment ANDOVER, Mass., Sept.
OWINGS MILLS, Md., Sept. 12, 2014 /PRNewswire-USNewswire/ -- September not only marks the end of summer and the start of football season, but is also National Prostate Cancer Awareness Month.
Results Suggest that Oncotype DX® Colon Cancer Test May Reduce Medical Costs Associated with Stage II Disease While Increasing Patient Well-being REDWOOD CITY, Calif., Sept.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.
More Images (2 images) »